ENTXEntera Bio Ltd.vs its industry peers
A metric-by-metric comparison of Entera Bio Ltd. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENTXThis | $542M#3 | 8.9x#2 | 74.6x#3 | 12903.2x#4 | -76.8%#6 | -19.9%#5 | -27450.0%#6 | -157.4%#4 | — | — | — | — |
| CRDL | $102M#5 | — | — | — | — | — | — | — | — | — | — | — |
| CYVNY | — | — | — | — | -80.0%#7 | 26.1%#3 | -623048.0%#7 | — | — | — | — | — |
| DBVT | $3.1B#1 | — | 21.1x#2 | 555.3x#3 | 35.8%#2 | -29.0%#6 | -2609.2%#4 | -98.9%#2 | — | — | -30.4%#1 | — |
| DBVTF | — | — | — | — | 35.8%#2 | -29.0%#6 | -2609.2%#4 | -98.9%#2 | — | — | — | — |
| ELUT | — | 0.8x#1 | — | — | -15.0%#5 | 198.9%#1 | -218.9%#3 | 339.0%#1 | -122.6%#2 | — | — | — |
| EVAX | $1.2B#2 | — | — | 165.1x#2 | 125.1%#1 | 27.1%#2 | -122.7%#2 | — | — | — | — | — |
| FENC | $362M#4 | — | 8.5x#1 | 8.1x#1 | -6.1%#4 | -2134.2%#8 | -14.1%#1 | -22951.3%#5 | -23.1%#1 | — | — | — |
| GNTA | $22M#6 | — | — | — | — | — | — | — | — | — | — | — |
| GPLB | — | — | — | — | — | -0.8%#4 | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-05.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice